It is currently 22 Nov 2017, 17:29

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

Systemic lupus ethematosus (SLE) is an autoimmune disease characterize

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

Senior SC Moderator
User avatar
D
Joined: 14 Nov 2016
Posts: 1242

Kudos [?]: 1301 [0], given: 434

Location: Malaysia
GMAT ToolKit User Premium Member CAT Tests
Systemic lupus ethematosus (SLE) is an autoimmune disease characterize [#permalink]

Show Tags

New post 10 Oct 2017, 04:54
Question 1
00:00
A
B
C
D
E

Question Stats:

71% (01:34) correct 29% (02:03) wrong based on 21

HideShow timer Statistics

Question 2
00:00
A
B
C
D
E

Question Stats:

57% (00:46) correct 43% (00:18) wrong based on 21

HideShow timer Statistics

Source : PowerScore Reading Comprehension Bible
Systemic lupus ethematosus (SLE) is an autoimmune disease characterized by the aberrant and chronic stimulation of the innate immune system—our first line of defense against infection. Under normal circumstances, immune cells are recruited to sites of infection through the production of chemical factors called cytokines. In patients with SLE, cytokines recruit cells to attack normal, healthy tissues without the presence of an infectious pathogen. This results in the proliferation of antibody-immune complexes that cause inflammation and damage to the kidneys, blood vessels, and skin.

Patients with SLE are often treated with courses of strong immunosupressive drugs, such as cytotoxic drugs, antimalarial compounds and glucocorticoids. While glucocorticoid therapy is considered the most effective course of treatment, it is regrettably transient, requiring more aggressive (and potentially more harmful) treatments, such as high-dose methylprednisolone pulse therapy. Discovering why glucocorticoid therapy fails to provide lasting relief has been the subject of numerous recent studies. The main culprit seems to be the plasmacytoid dendritic cells (pDC)—innate immune cells that circulate in the blood and are found in the peripheral lymphoid organs. While pDCs are normally susceptible to treatment with glucocorticoids, they are resistant to such treatment in patients with SLE. And, since pDCs are responsible for producing the key cytokines involved in SLE pathogenesis, the level of thesecytokines does not substantially decrease with treatment, and symptoms quickly relapse. The precise mechanism by which pDC resistance occurs is still unknown.

[Reveal] Spoiler:
C

1. In the passage the author is primarily concerned with doing which of the following?

(A) outlining the mechanism by which immune cells attack healthy tissues in patients with SLE
(B) demonstrating the difficulties that must be overcome if a satisfactory cure for SLE is to be found
(C) describing the pathogenesis of SLE and explaining why the disease is difficult to treat
(D) showing why one explanation of the difficulties involved in treating SLE falls short in explaining these difficulties
(E) evaluating the evidence supporting the explanation as to why SLE is difficult to treat


[Reveal] Spoiler:
E

2. Which of the following best states the central idea of the passage?

(A) Identifying a cure for SLE requires understanding the precise mechanism by which pDC resistance occurs.
(B) Scientists have made little progress in the treatment of SLE.
(C) Successful treatment of SLE requires reducing the harmful effects of antibody-immune complexes on healthy tissues.
(D) In patients with SLE, the risks associated with the currently available courses of treatment outweigh the benefits of such treatments.
(E) Despite recent advances in our understanding of the immune system, a satisfactory course of treatment for patients with SLE is yet to be found.

[Reveal] Spoiler: Question #1 OA
[Reveal] Spoiler: Question #2 OA

_________________

"Be challenged at EVERY MOMENT."

“Strength doesn’t come from what you can do. It comes from overcoming the things you once thought you couldn’t.”

"Each stage of the journey is crucial to attaining new heights of knowledge."

Rules for posting in verbal forum | Please DO NOT post short answer in your post!

Kudos [?]: 1301 [0], given: 434

Manager
Manager
avatar
P
Joined: 06 Jan 2015
Posts: 237

Kudos [?]: 111 [0], given: 469

Location: India
Concentration: Operations, Finance
GPA: 3.35
WE: Information Technology (Computer Software)
Systemic lupus ethematosus (SLE) is an autoimmune disease characterize [#permalink]

Show Tags

New post 11 Oct 2017, 20:10
hazelnut What is the difference between the author is primarily concerned with doing which of the following and central idea of the passage?

Do you have the explanation?
_________________

आत्मनॊ मोक्षार्थम् जगद्धिताय च

Resource: GMATPrep RCs With Solution

Kudos [?]: 111 [0], given: 469

Systemic lupus ethematosus (SLE) is an autoimmune disease characterize   [#permalink] 11 Oct 2017, 20:10
Display posts from previous: Sort by

Systemic lupus ethematosus (SLE) is an autoimmune disease characterize

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.